Lutikizumab
Lutikizumab Basic information
- Product Name:
- Lutikizumab
- Synonyms:
-
- Lutikizumab
- Research Grade Lutikizumab
- CAS:
- 1791411-57-8
- MW:
- 0
- Mol File:
- Mol File
More
Less
Lutikizumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Lutikizumab Usage And Synthesis
Uses
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis[1].
in vivo
Lutikizumab (0.0001-1 mg/kg, i.p., once) shows effective inhibition to the IL-6 production induced by IL-1α and IL-1β[1].
| Animal Model: | Female C57/BL6 mice with IL-1α and IL-1β injection[1] |
| Dosage: | 0.0001-1 mg/kg |
| Administration: | Intraperitoneal injection, 0.0001-1 mg/kg, once |
| Result: | Dose-dependently decreased the murine IL-6 generated by human and cynomolgus IL-1α and IL-1β. |
References
[1] Lacy SE, et al. Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β. MAbs. 2015;7(3):605-19. DOI:10.1080/19420862.2015.1026501
LutikizumabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
Wuhan Jingkangen Biomedical Technology Co., Ltd
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com